Implementing Disease Management Programs for Type 2 Diabetes in Germany
More like this
- Could German Drug Price Transparency Come to the U.S.?
- Headlines On Deadline...
- Can Self-Management Programs Ease Chronic Conditions?
- Evaluating the Nondrug Costs of Formulary Coverage Restrictions
- A Comparison of Diabetes Patients' Self-Reported Health Status With Hemoglobin A1c Test Results In 11 California Health Plans
|Customer Analytics & Engagement in Health Insurance||Chicago||December 4–5, 2014|
|Pharmaceutical and Biotech Clinical Quality Assurance Conference||Alexandria, VA||December 4–5, 2014|
|6th Semi-Annual Diagnostic Coverage and Reimbursement Conference||Boston||December 4–5, 2014|
|9th Semi-Annual Medical Device Coverage and Reimbursement Conference||San Diego||December 5, 2014|
|8th Annual Medical Device Clinical Trials Conference||Chicago||December 8–9, 2014|
|HealthIMPACT Southeast||Tampa, FL||January 23, 2015|